PL358081A1 - Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt - Google Patents

Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt

Info

Publication number
PL358081A1
PL358081A1 PL02358081A PL35808102A PL358081A1 PL 358081 A1 PL358081 A1 PL 358081A1 PL 02358081 A PL02358081 A PL 02358081A PL 35808102 A PL35808102 A PL 35808102A PL 358081 A1 PL358081 A1 PL 358081A1
Authority
PL
Poland
Prior art keywords
inclusion bodies
antigenes
animals
oral immunization
oral
Prior art date
Application number
PL02358081A
Other languages
English (en)
Other versions
PL196114B1 (pl
Inventor
Andrzej Płucienniczak
Małgorzata Kęsik
Anna Porębska
Halina Wędrychowicz
Luiza Jedlina-Panasiuk
Original Assignee
Instytut Biotechnologii i Antybiotyków
Instytut Parazytologii Pan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biotechnologii i Antybiotyków, Instytut Parazytologii Pan filed Critical Instytut Biotechnologii i Antybiotyków
Priority to PL358081A priority Critical patent/PL196114B1/pl
Priority to EP03789657A priority patent/EP1578791B1/en
Priority to PCT/PL2003/000151 priority patent/WO2004058816A2/en
Priority to DE60319741T priority patent/DE60319741T2/de
Priority to NZ541291A priority patent/NZ541291A/en
Priority to AT03789657T priority patent/ATE388962T1/de
Priority to AU2003294191A priority patent/AU2003294191B2/en
Publication of PL358081A1 publication Critical patent/PL358081A1/pl
Publication of PL196114B1 publication Critical patent/PL196114B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL358081A 2002-12-31 2002-12-31 Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt PL196114B1 (pl)

Priority Applications (7)

Application Number Priority Date Filing Date Title
PL358081A PL196114B1 (pl) 2002-12-31 2002-12-31 Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt
EP03789657A EP1578791B1 (en) 2002-12-31 2003-12-31 Inclusion bodies for the oral vaccination of animals
PCT/PL2003/000151 WO2004058816A2 (en) 2002-12-31 2003-12-31 Inclusion bodies for the oral vaccination of animals
DE60319741T DE60319741T2 (de) 2002-12-31 2003-12-31 Einschlusskörper für die mündliche impfung von tieren
NZ541291A NZ541291A (en) 2002-12-31 2003-12-31 Inclusion bodies for the oral vaccination of animals
AT03789657T ATE388962T1 (de) 2002-12-31 2003-12-31 Einschlusskörper für die mündliche impfung von tieren
AU2003294191A AU2003294191B2 (en) 2002-12-31 2003-12-31 Inclusion bodies for the oral vaccination of animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL358081A PL196114B1 (pl) 2002-12-31 2002-12-31 Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt

Publications (2)

Publication Number Publication Date
PL358081A1 true PL358081A1 (pl) 2004-07-12
PL196114B1 PL196114B1 (pl) 2007-12-31

Family

ID=32678127

Family Applications (1)

Application Number Title Priority Date Filing Date
PL358081A PL196114B1 (pl) 2002-12-31 2002-12-31 Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt

Country Status (7)

Country Link
EP (1) EP1578791B1 (pl)
AT (1) ATE388962T1 (pl)
AU (1) AU2003294191B2 (pl)
DE (1) DE60319741T2 (pl)
NZ (1) NZ541291A (pl)
PL (1) PL196114B1 (pl)
WO (1) WO2004058816A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2321640B1 (en) 2008-08-21 2016-11-30 Immunogenics LLC Formulation for oral administration of proteins
EP2251025A1 (en) * 2009-05-12 2010-11-17 Universitat Autònoma De Barcelona Use of inclusion bodies as therapeutic agents
NL2023863B1 (en) * 2019-09-20 2021-05-25 Univ Griffith Protein particles and uses thereof
CN116514993B (zh) * 2023-03-29 2023-09-29 中山大学附属第三医院 一种肝吸虫口服芽孢疫苗及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9404004A (pt) * 1993-02-05 1999-05-25 Daratech Pty Ltd Poliptídeo isolado fragmento antigênico parte derivado ou análogo molécula de ácido nucléico método para reduzir o alastramento de um parasita helmíntico e composição de vacina
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina

Also Published As

Publication number Publication date
AU2003294191A8 (en) 2004-07-22
PL196114B1 (pl) 2007-12-31
AU2003294191A1 (en) 2004-07-22
DE60319741T2 (de) 2009-04-02
DE60319741D1 (de) 2008-04-24
WO2004058816A3 (en) 2004-10-14
WO2004058816A2 (en) 2004-07-15
ATE388962T1 (de) 2008-03-15
AU2003294191B2 (en) 2010-11-25
NZ541291A (en) 2008-06-30
EP1578791B1 (en) 2008-03-12
EP1578791A2 (en) 2005-09-28

Similar Documents

Publication Publication Date Title
WO2004032829A3 (en) Immunostimulatory compositions and methods of stimulating an immune response
NO20070699L (no) Spesielle aminoalkylglukosaminidfosfatforbindelser og deres anvendelse
EP1594536A4 (en) ADJUVANT INFLUENZA VACCINE
EP1706146A4 (en) NUTRIENT COMPOSITIONS AND METHODS FOR IMPROVING THE EFFECTIVENESS OF THE IMMUNE SYSTEM
CA105195S (en) Bottle
AU2003235707A1 (en) Immunogenic preparations and vaccines on the basis of mrna
EP1729768A4 (en) FORMULATIONS AND METHOD FOR MODIFYING THE IMMUNE RESPONSE
CA101100S (en) Pillow
EA201170493A1 (ru) Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот
DE69431358D1 (de) Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien
IL210378A0 (en) Tumor associated antigen, peptides thereof, and use of same as ati-tumor vaccines
BR122018075729B8 (pt) flavivírus na preparação de uma composição de vacina
IL188222A (en) Immunological preparations and their use in vaccinating animals against tuberculosis
AU2008243079A1 (en) Compositions and methods for generating an immune response
GB0320020D0 (en) Improved formulation for providing an enteric coating material
ATE511855T1 (de) Adjuvansformulierung zur scheimhaut-applikation
EP1549135A4 (en) VACCINE AND ADJUVANT COMPOSITIONS
PL380950A1 (pl) Pewne związki amionoalkiloglukozaminidofosforanowe i ich zastosowanie
EP1471936A4 (en) HIV VACCINE AND METHOD OF USE
WO2008133651A3 (en) Ablative immunotherapy
MX2008011844A (es) Formulaciones de sitaxsentano de sodio.
PL358081A1 (pl) Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt
WO2004067564A3 (en) Compositions against cancer antigen liv-1 and uses thereof
EA200700017A1 (ru) Способ усиления иммунного ответа на вакцину
WO2003093298A3 (en) Immunogenic peptides